263 related articles for article (PubMed ID: 16524698)
1. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
2. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
3. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
[TBL] [Abstract][Full Text] [Related]
4. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
[TBL] [Abstract][Full Text] [Related]
5. Clozapine metabolism rate as a possible index of drug-induced granulocytopenia.
Mauri MC; Rudelli R; Bravin S; Gianetti S; Giuliani E; Guerrini A; Orlandi R; Invernizzi G
Psychopharmacology (Berl); 1998 Jun; 137(4):341-4. PubMed ID: 9676893
[TBL] [Abstract][Full Text] [Related]
6. Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients.
Lee ST; Ryu S; Nam HJ; Lee SY; Hong KS
Int Clin Psychopharmacol; 2009 May; 24(3):139-44. PubMed ID: 19194306
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations.
Augustin M; Schoretsanitis G; Pfeifer P; Gründer G; Liebe C; Paulzen M
Schizophr Res; 2019 Aug; 210():143-148. PubMed ID: 31182321
[TBL] [Abstract][Full Text] [Related]
8. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders.
Marazziti D; Palego L; Betti L; Giannaccini G; Massimetti E; Baroni S; Ciapparelli A; Lucacchini A; Mucci F; DellʼOsso L
Ther Drug Monit; 2018 Aug; 40(4):443-451. PubMed ID: 29601407
[TBL] [Abstract][Full Text] [Related]
9. Validated GC/MS method for the simultaneous determination of clozapine and norclozapine in human plasma. Application in psychiatric patients under clozapine treatment.
Vardakou I; Dona A; Pistos C; Alevisopoulos G; Athanaselis S; Maravelias C; Spiliopoulou C
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2327-32. PubMed ID: 20674521
[TBL] [Abstract][Full Text] [Related]
10. Whole saliva and plasma levels of clozapine and desmethylclozapine.
Dumortier G; Lochu A; Zerrouk A; Van Nieuwenhuyse V; Colen de Melo P; Roche Rabreau D; Degrassat K
J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110
[TBL] [Abstract][Full Text] [Related]
11. Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia.
Vaquero-Baez M; Díaz-Ruíz A; Tristán-López L; Aviña-Cervantes C; Torner C; Ramírez-Bermúdez J; Montes S; Ríos C
BMC Psychiatry; 2019 Oct; 19(1):295. PubMed ID: 31597566
[TBL] [Abstract][Full Text] [Related]
12. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
13. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL
J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?
Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
Chem Biol Interact; 2022 Sep; 364():110042. PubMed ID: 35853541
[TBL] [Abstract][Full Text] [Related]
15. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of clozapine in relapse prevention: a five-year prospective study.
Gaertner I; Gaertner HJ; Vonthein R; Dietz K
J Clin Psychopharmacol; 2001 Jun; 21(3):305-10. PubMed ID: 11386494
[TBL] [Abstract][Full Text] [Related]
17. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
Perry PJ; Miller DD; Arndt SV; Cadoret RJ
Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model.
Dal Santo F; Jarratt-Barnham I; González-Blanco L; García-Portilla MP; Bobes J; Fernández-Egea E
Eur Neuropsychopharmacol; 2020 Apr; 33():158-163. PubMed ID: 32057590
[TBL] [Abstract][Full Text] [Related]
19. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.
Carrillo JA; Herraiz AG; Ramos SI; Benítez J
J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697
[TBL] [Abstract][Full Text] [Related]
20. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
